de los Santos‐Fernández, R. L., Segovia‐Zafra, A., Paz‐López, G., Matilla‐Cabello, G., Niu, H., Álvarez‐Álvarez, I., Stephens, C., González‐Jiménez, A., Lucena, M. I., Andrade, R. J., & Medina‐Cáliz, I. (2025). Epigenetic modifications in drug‐induced liver injury: A systematic review. British Journal of Clinical Pharmacology, 91(6), 1660–1674. Portico. https://doi.org/10.1002/bcp.70053

Paz-López, G., Linares-Pineda, T. M., González-Jiménez, A., Sancho-Marín, R., Ocaña-Wilhelmi, L., Tinahones, F. J., Morcillo, S., & Gutiérrez-Repiso, C. (2025). Pre-operative DNA methylation marks as predictors of weight loss outcomes after sleeve gastrectomy. Molecular Metabolism, 92, 102087. https://doi.org/10.1016/j.molmet.2024.102087

Mela, V., Martín-Reyes, F., Oliva-Olivera, W., Cantarero-Cuenca, A., Sánchez-García, A., Sancho-Marín, R., González-Jimenez, A., Tomé, M., Moreno-Ruiz, F. J., Soler-Humanes, R., Fernández-Serrano, J. L., Sanchez-Gallegos, P., Martínez-Moreno, J. M., Tinahones, F. J., García-Fuentes, E., & Garrido-Sánchez, L. (2025). Serum miR-365b-5p/miR-222-5p as a potential diagnostic biomarker for long-term weight loss in patients with morbid obesity after bariatric surgery. Metabolism, 165, 156129. https://doi.org/10.1016/j.metabol.2024.156129

Ariza, M. J., Coca-Prieto, I., Rioja, J., Muñiz-Grijalvo, O., Zambón-Rados, D., Blanco-Echevarría, A., Arrobas-Velilla, T., Delgado-Lista, J., León-Jiménez, D., Casañas-Martínez, M., Álvarez-Sala, L. A., Gutiérrez-Carrasquilla, L., Sánchez-Gil, J., Domènech, M., González-Jiménez, A., Benítez-Toledo, M. J., Espíldora-Hernández, J., Ortega-Martínez de Victoria, E., Sánchez-Chaparro, M. Á., & Valdivielso, P. (2025). Pathogenicity assessment of genetic variants identified in patients with severe hypertriglyceridemia: Novel cases of familial chylomicronemia syndrome from the Dyslipidemia Registry of the Spanish Atherosclerosis Society. Genetics in Medicine, 27(5), 101365. https://doi.org/10.1016/j.gim.2025.101365

Bermúdez-Pérez, I. V., Alvarez-Alvarez, I., Medina-Cáliz, I., Robles-Diaz, M., Niu, H., Chen, M., Andrade, R. J., Lucena, M. I., Stephens, C., & Gonzalez-Jimenez, A. (2025). Evaluation of the role of comedication properties in the severity of drug-induced liver injury using machine learning techniques. Expert Opinion on Drug Metabolism &Amp; Toxicology, 21(8), 1001–1008. https://doi.org/10.1080/17425255.2025.2525470

Mucientes, A., Núñez, G. M. M., Mena-Vázquez, N., Lisbona-Montañez, J. M., Manrique-Arija, S., González-Jiménez, A., Ruiz-Limón, P., Garcia-Studer, A., Ortiz-Márquez, F., Cano-García, L., & Fernández-Nebro, A. (2025). Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study. Arthritis Research &Amp; Therapy, 27(1). https://doi.org/10.1186/s13075-025-03628-2

Ruiz-Molina, Y., Padial, M., Martín-Bravo, M. d. M., García-Olivares, M., Porras, N., Chicharro, A., Mora-Robles, J., González-Jiménez, A., Sasso, C. V., & Olveira, G. (2025). Targeting Lymphedema in Overweight Breast Cancer Survivors: A Pilot Randomized Controlled Trial of Diet and Exercise Intervention. Nutrients, 17(17), 2768. https://doi.org/10.3390/nu17172768

Campanelli, L., Sendoya, J. M., Brody, S., Galeano, P., Do Carmo, S., Cuello, A. C., Castaño, E. M., Gonzalés-Jimenez, A., Verheul, J., Medina-Vera, D., de Fonseca, F. R., Wernersson, R., & Morelli, L. (2025). New insights into the molecular biology of Alzheimer’s-like cerebral amyloidosis achieved through multi‐omics approaches. PLOS One, 20(9), e0330859. https://doi.org/10.1371/journal.pone.0330859

Gómez-García, I., Ladehesa-Pineda, M. L., Diaz-Tocados, J. M., López-Medina, C., Abalos-Aguilera, M. C., Ruiz-Vilches, D., Paz-Lopez, G., Gonzalez-Jimenez, A., Ranea, J. A. G., Escudero-Contreras, A., Moreno-Indias, I., Tinahones, F. J., Collantes-Estévez, E., & Ruiz-Limón, P. (2024). Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1227196

Rodriguez-Muñoz, A., Motahari-Rad, H., Martin-Chaves, L., Benitez-Porres, J., Rodriguez-Capitan, J., Gonzalez-Jimenez, A., Insenser, M., Tinahones, F. J., & Murri, M. (2024). A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle. Current Obesity Reports, 13(3), 403–438. https://doi.org/10.1007/s13679-024-00561-4

Vargas-Molina, S., Murri, M., Gonzalez-Jimenez, A., Gómez-Urquiza, J. L., & Benítez-Porres, J. (2024). Effects of the Ketogenic Diet on Strength Performance in Trained Men and Women: A Systematic Review and Meta-Analysis. Nutrients, 16(14), 2200. https://doi.org/10.3390/nu16142200

Cantarero-Cuenca, A., Gonzalez-Jimenez, A., Martínez-Núñez, G. M., Garrido-Sánchez, L., Ranea, J. A. G., & Tinahones, F. J. (2024). Epigenetic profiles in blood and adipose tissue: identifying strong correlations in morbidly obese and non-obese patients. Journal of Molecular Medicine, 102(11), 1315–1325. https://doi.org/10.1007/s00109-024-02475-z

Martínez-Montoro, J. I., Martín-Núñez, G. M., González-Jiménez, A., Garrido-Sánchez, L., Moreno-Indias, I., & Tinahones, F. J. (2024). Interactions between the gut microbiome and DNA methylation patterns in blood and visceral adipose tissue in subjects with different metabolic characteristics. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05746-y

Gomez‐Casado, G., Jimenez‐Gonzalez, A., Rodriguez‐Muñoz, A., Tinahones, F. J., González‐Mesa, E., Murri, M., & Ortega‐Gomez, A. (2024). Neutrophils as indicators of obesity‐associated inflammation: A systematic review and meta‐analysis. Obesity Reviews, 26(3). Portico. https://doi.org/10.1111/obr.13868

Murcia Casas, B., Carrillo Linares, J. L., Baquero Aranda, I., Rioja Villodres, J., Merino Bohórquez, V., González Jiménez, A., Rico Corral, M. Á., Bosch, R., Sánchez Chaparro, M. Á., García Fernández, M., & Valdivielso, P. (2023). Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial. International Journal of Molecular Sciences, 24(5), 4899. https://doi.org/10.3390/ijms24054899

Sánchez-Quintero, M. J., Delgado, J., Martín Chaves, L., Medina-Vera, D., Murri, M., Becerra-Muñoz, V. M., Estévez, M., Crespo-Leiro, M. G., Paz López, G., González-Jiménez, A., A. G. Ranea, J., Queipo-Ortuño, M. I., Plaza-Andrades, I., Rodríguez-Capitán, J., Pavón-Morón, F. J., & Jiménez-Navarro, M. F. (2023). Multi-Omics Approach Reveals Prebiotic and Potential Antioxidant Effects of Essential Oils from the Mediterranean Diet on Cardiometabolic Disorder Using Humanized Gnotobiotic Mice. Antioxidants, 12(8), 1643. https://doi.org/10.3390/antiox12081643

Gutiérrez-Repiso, C., Cantarero-Cuenca, A., González-Jiménez, A., Linares-Pineda, T., Peña-Montero, N., Ocaña-Wilhelmi, L., Tinahones, F. J., & Morcillo, S. (2023). Epigenetic Marks as Predictors of Metabolic Response to Bariatric Surgery: Validation from an Epigenome Wide Association Study. International Journal of Molecular Sciences, 24(19), 14778. https://doi.org/10.3390/ijms241914778

Martínez-Montoro, J. I., Ocaña-Wilhelmi, L., Soler-Humanes, R., Motahari-Rad, H., González-Jiménez, A., Rivas-Becerra, J., Rodríguez-Muñoz, A., Moreno-Ruiz, F. J., Tomé, M., Rodríguez-Capitán, J., García-Fuentes, E., Tinahones, F. J., Garrido-Sánchez, L., & Murri, M. (2022). Evaluation of Adipose Tissue Zinc-Alpha 2-Glycoprotein Gene Expression and Its Relationship with Metabolic Status and Bariatric Surgery Outcomes in Patients with Class III Obesity. Biomedicines, 10(7), 1502. https://doi.org/10.3390/biomedicines10071502

Hayashi, P. H., Lucena, M. I., Fontana, R. J., Bjornsson, E. S., Aithal, G. P., Barnhart, H., Gonzalez‐Jimenez, A., Yang, Q., Gu, J., Andrade, R. J., & Hoofnagle, J. H. (2022). A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology, 76(1), 18–31. https://doi.org/10.1002/hep.32327

Mela, V., Ruiz-Limón, P., Balongo, M., Motahari Rad, H., Subiri-Verdugo, A., Gonzalez-Jimenez, A., Soler, R., Ocaña, L., el Azzouzi, H., Tinahones, F. J., Valdivielso, P., & Murri, M. (2022). Mitochondrial Homeostasis in Obesity-related Hypertriglyceridemia. The Journal of Clinical Endocrinology &Amp; Metabolism, 107(8), 2203–2215. https://doi.org/10.1210/clinem/dgac332

Moya-García, A. A., González-Jiménez, A., Moreno, F., Stephens, C., Lucena, M. I., & Ranea, J. A. G. (2022). Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology. Genes, 13(7), 1292. https://doi.org/10.3390/genes13071292

Stephens, C., Robles-Diaz, M., Medina-Caliz, I., Garcia-Cortes, M., Ortega-Alonso, A., Sanabria-Cabrera, J., Gonzalez-Jimenez, A., Alvarez-Alvarez, I., Slim, M., Jimenez-Perez, M., Gonzalez-Grande, R., Fernández, M. C., Casado, M., Soriano, G., Román, E., Hallal, H., Romero-Gomez, M., Castiella, A., Conde, I., et al. (2021). Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. Journal of Hepatology, 75(1), 86–97. https://doi.org/10.1016/j.jhep.2021.01.029

Ashby, K., Zhuang, W., González-Jimenez, A., Alvarez-Alvarez, I., Lucena, M. I., Andrade, R. J., Aithal, G. P., Suzuki, A., & Chen, M. (2021). Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI. Journal of Hepatology, 75(2), 333–341. https://doi.org/10.1016/j.jhep.2021.03.021

Gonzalez-Jimenez, A., Suzuki, A., Chen, M., Ashby, K., Alvarez-Alvarez, I., Andrade, R. J., & Lucena, M. I. (2021). Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach. Archives of Toxicology, 95(5), 1793–1803. https://doi.org/10.1007/s00204-021-03013-3

Gutiérrez-Repiso, C., Linares-Pineda, T. M., Gonzalez-Jimenez, A., Aguilar-Lineros, F., Valdés, S., Soriguer, F., Rojo-Martínez, G., Tinahones, F. J., & Morcillo, S. (2021). Epigenetic Biomarkers of Transition from Metabolically Healthy Obesity to Metabolically Unhealthy Obesity Phenotype: A Prospective Study. International Journal of Molecular Sciences, 22(19), 10417. https://doi.org/10.3390/ijms221910417

Sanabria‐Cabrera, J., Sanjuán‐Jiménez, R., Clavijo, E., Medina‐Cáliz, I., González‐Jiménez, A., García‐Cortés, M., Ortega‐Alonso, A., Jiménez‐Pérez, M., González‐Grande, R., Stephens, C., Robles‐Díaz, M., Lucena, M. I., Andrade, R. J., & . (2020). Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug‐Induced Liver Injury in the Spanish DILI Registry. Liver International, 41(7), 1523–1531. Portico. https://doi.org/10.1111/liv.14713

Zoubek, M. E., Pinazo-Bandera, J., Ortega-Alonso, A., Hernández, N., Crespo, J., Contreras, F., Medina-Cáliz, I., Sanabria-Cabrera, J., Sanjuan-Jiménez, R., González-Jiménez, A., García-Cortés, M., Lucena, M. I., Andrade, R. J., & Robles-Díaz, M. (2019). Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review. United European Gastroenterology Journal, 7(6), 825–837. Portico. https://doi.org/10.1177/2050640619840147

Zoubek, M. E., González-Jimenez, A., Medina-Cáliz, I., Robles-Díaz, M., Hernandez, N., Romero-Gómez, M., Bessone, F., Hallal, H., Cubero, F. J., Lucena, M. I., Stephens, C., & Andrade, R. J. (2018). High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries. Clinical Gastroenterology and Hepatology, 16(2), 292–294. https://doi.org/10.1016/j.cgh.2017.07.037

Medina-Caliz, I., Garcia-Cortes, M., Gonzalez-Jimenez, A., Cabello, M. R., Robles-Diaz, M., Sanabria-Cabrera, J., Sanjuan-Jimenez, R., Ortega-Alonso, A., García-Muñoz, B., Moreno, I., Jimenez-Perez, M., Fernandez, M. C., Ginés, P., Prieto, M., Conde, I., Hallal, H., Soriano, G., Roman, E., Castiella, A., et al. (2018). Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry. Clinical Gastroenterology and Hepatology, 16(9), 1495–1502. https://doi.org/10.1016/j.cgh.2017.12.051

Medina-Caliz, I., Gonzalez-Jimenez, A., Garcia-Cortes, M., Lucena, M. I., & Andrade, R. (2018). Hepatic Damage by Natural Remedies. Seminars in Liver Disease, 38(01), 021–040. https://doi.org/10.1055/s-0038-1623518

Gonzalez‐Jimenez, A., McEuen, K., Chen, M., Suzuki, A., Robles‐Diaz, M., Medina‐Caliz, I., Bessone, F., Hernandez, N., Arrese, M., Parana, R., Lucena, M. I., Stephens, C., & Andrade, R. J. (2018). The influence of drug properties and host factors on delayed onset of symptoms in drug‐induced liver injury. Liver International, 39(2), 401–410. Portico. https://doi.org/10.1111/liv.13952

Gonzalez-Jimenez, A., Medina-Cáliz, I., Robles-Díaz, M., Zoubek, M. E., Díaz-Jimenez, P., Cabello, M. R., Ortega-Alonso, A., García-Cortes, M., García-Muñoz, B., Fernandez, M. C., Slim, M., Romero-Gómez, M., Bessone, F., Hernandez, N., Arrese, M., Montane, E., Hallal, H., Sanabria-Cabrera, J. A., Sanjuan-Jimenez, R., et al. (2016). Hepatotoxicity Associated with Non-Steroidal Anti-Inflammatory Drugs. A Comparative Analysis among Ibuprofen, Diclofenac and Nimesulide fromthe Spanish and Latin-American Dili Registries. Journal of Hepatology, 64(2), S239–S240. https://doi.org/10.1016/s0168-8278(16)00239-7

Medina-Caliz, I., Robles-Diaz, M., Garcia-Muñoz, B., Stephens, C., Ortega-Alonso, A., Garcia-Cortes, M., González-Jimenez, A., Sanabria-Cabrera, J. A., Moreno, I., Fernandez, M. C., Romero-Gomez, M., Navarro, J. M., Barriocanal, A. M., Montane, E., Hallal, H., Blanco, S., Soriano, G., Roman, E. M., Gómez-Dominguez, E., et al. (2016). Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. Journal of Hepatology, 65(3), 532–542. https://doi.org/10.1016/j.jhep.2016.05.003

Slim, M., Medina-Caliz, I., Gonzalez-Jimenez, A., Cabello, M. R., Mayoral-Cleries, F., Lucena, M. I., & Andrade, R. J. (2016). Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Safety, 39(10), 925–943. https://doi.org/10.1007/s40264-016-0436-7

Robles-Díaz, M., Medina-Cáliz, I., Ruíz, A., Sanabria, J., Stephens, C., González-Jiménez, A., Ortega-Alonso, A., García-Muñoz, B., García-Cortés, M., Romero-Gómez, M., Peláez, G., Hallal, H., Soriano, G., Román, E., Blanco, S., Castiella, A., Zapata, E. M., Navarro, J. M., Jiménez, M., et al. (2015). P1098 : Influence of metabolic risk factors in hepatotoxicity (DILI) phenotype and outcome. Journal of Hepatology, 62, S761–S762. https://doi.org/10.1016/s0168-8278(15)31295-2

Ortega-Alonso, A., Castiella, A., Robles-Diaz, M., Medina-Caliz, I., Stephens, C., Sanabria, J., Gonzalez-Jimenez, A., Garcia-Muñoz, B., Garcia-Cortes, M., Zapata, E. M., Otazua, P., Blanco, S., Prieto, M., Bessone, F., Fernandez, M. C., Hallal, H., Primo, J., Moreno-Planas, J. M., Arrese, M., et al. (2015). P1097 : Distinguishing drug induced autoimmune hepatitis from idiopatic autoimmune hepatitis. Journal of Hepatology, 62, S761. https://doi.org/10.1016/s0168-8278(15)31294-0

Sanabria-Cabrera, J., Robles-Díaz, M., Medina-Cáliz, I., Stephens, C., Ruíz, A., González-Jiménez, A., Ortega-Alonso, A., García-Cortés, M., García-Muñoz, B., Romero-Gómez, M., Fernández, M. C., Hallal, H., Soriano, G., Román, E., Blanco, S., Castiella, A., Zapata, E. M., Navarro, J. M., Jiménez, M., et al. (2015). Metabolic risk factors affect clinical Phenotype and outcome of Hepatotoxicity (DILI). Clinical Therapeutics, 37(8), e126–e127. https://doi.org/10.1016/j.clinthera.2015.05.360

Medina-Cáliz, I., Robles-Díaz, M., Stephens, C., González-Jiménez, A., Sanabria-Cabrera, J., Ortega-Alonso, A., García-Cortés, M., Mirwani, S., Thorpe, B., Jiménez-Pérez, M., Fernández, M. C., Navarro, J. M., Montané, E., Barriocanal, A. M., Prieto, M., García-Eliz, M., Bessone, F., Hernández, N., Carrera, E., et al. (2015). Hepatotoxicity related to Herbals and Dietary Supplements (HDS): a cause for concern. Clinical Therapeutics, 37(8), e123. https://doi.org/10.1016/j.clinthera.2015.05.351

Robles‐Diaz, M., Garcia‐Cortes, M., Medina‐Caliz, I., Gonzalez‐Jimenez, A., Gonzalez‐Grande, R., Navarro, J. M., Castiella, A., Zapata, E. M., Romero‐Gomez, M., Blanco, S., Soriano, G., Hidalgo, R., Ortega‐Torres, M., Clavijo, E., Bermudez‐Ruiz, P. M., Lucena, M. I., & Andrade, R. J. (2015). The value of serum aspartate aminotransferase and gamma‐glutamyl transpetidase as biomarkers in hepatotoxicity. Liver International, 35(11), 2474–2482. Portico. https://doi.org/10.1111/liv.12834

Medina-Cáliz, I., González-Jiménez, A., Robles-Díaz, M., Stephens, C., Cabello, M., García-Muñoz, B., García-Cortés, M., Alcántara, R., González-Grande, R., Jiménez, M., Rendón, P., Navarro, J. M., Méndez, I. M., Bessone, F., Ginés, P., Alfaro, I., Brahm, J. R., Paraná, R., Schinoni, M. I., et al. (2014). P310 ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH–LATIN-AMERICAN DILI REGISTRY. Journal of Hepatology, 60(1), S169. https://doi.org/10.1016/s0168-8278(14)60472-4

Andrade, R. J., Robles-Díaz, M., Stephens, C., Medina-Cáliz, I., González-Jiménez, A., González, A. F., Kaplowitz, N., Fernández, M. C., Romero-Gómez, M., Jiménez-Pérez, M., Bruguera, M., Prieto, M., Bessone, F., Hernández, N., Arrese, M., & Lucena, M. I. (2014). P309 PROGNOSTIC MODEL FOR PREDICTING DRUG-INDUCED ACUTE LIVER FAILURE. Journal of Hepatology, 60(1), S169. https://doi.org/10.1016/s0168-8278(14)60471-2

Robles–Diaz, M., Lucena, M. I., Kaplowitz, N., Stephens, C., Medina–Cáliz, I., González–Jimenez, A., Ulzurrun, E., Gonzalez, A. F., Fernandez, M. C., Romero–Gómez, M., Jimenez–Perez, M., Bruguera, M., Prieto, M., Bessone, F., Hernandez, N., Arrese, M., & Andrade, R. J. (2014). Use of Hy’s Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury. Gastroenterology, 147(1), 109–118. https://doi.org/10.1053/j.gastro.2014.03.050

Robles‐Diaz, M., Gonzalez‐Jimenez, A., Medina‐Caliz, I., Stephens, C., García‐Cortes, M., García‐Muñoz, B., Ortega‐Alonso, A., Blanco‐Reina, E., Gonzalez‐Grande, R., Jimenez‐Perez, M., Rendón, P., Navarro, J. M., Gines, P., Prieto, M., Garcia‐Eliz, M., Bessone, F., Brahm, J. R., Paraná, R., Lucena, M. I., et al. (2014). Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Alimentary Pharmacology &Amp; Therapeutics, 41(1), 116–125. Portico. https://doi.org/10.1111/apt.13023

Bessone, F., Hernandez, N., Sanchez, A., di Pace, M., Arrese, M., Brahm, J. R., Ruiz, A., Arancibia, J., Kershenobich, D., Loaeza del Castillo, A., Girala, M., Paraná, R., Schinoni, M. I., Mendez-Sanchez, N., Medina-Cáliz, I., González-Jiménez, A., Stephens, C., Robles-Díaz, M., Lucena, M. I., & Andrade, R. J. (2013). 518 THE SPANISH–LATIN AMERICAN DILI NETWORK: PRELIMINARY RESULTS FROM A COLLABORATIVE STRATEGIC INITIATIVE. Journal of Hepatology, 58, S212–S213. https://doi.org/10.1016/s0168-8278(13)60520-6

Robles-Díaz, M., Stephens, C., Medina-Cáliz, I., González, A. F., González-Jiménez, A., Ulzurrun, E., Kaplowitz, N., Andrade, R. J., & Lucena, M. I. (2013). PP025—Improving hy’s law definition to better predict the risk of developing acute liver failure in drug-induced liver injury (DILI). Clinical Therapeutics, 35(8), e25. https://doi.org/10.1016/j.clinthera.2013.07.060

Medina-Cáliz, I., González-Jiménez, A., Bessone, F., Hernández, N., Sánchez, A., Di Pace, M., Arrese, M., Brahm, J. R., Ruíz, A., Arancibia, J., Kershenobich, D., Loaeza, A., Girala, M., Mendez-Sanchez, N., Dávalos, M., Lizarzabal, M., Mengual, E., Stephens, C., Robles-Díaz, M., et al. (2013). PP022—Variations in drug-induced liver injury (DILI) between different prospective dili registries. Clinical Therapeutics, 35(8), e24. https://doi.org/10.1016/j.clinthera.2013.07.057